Date de publication: 16 mars 2015
Promoteur – Intermédiaire Financier
GRIFOLS SALieu
Description
The project covers the promoter’s research activities in the fields of plasma-derived therapies, diagnostics and medical solutions for hospitals.
Objectifs
The project covers all stages of development i.e. pre-clinical development as well as clinical development. The project will be managed from the company’s headquarters in Barcelona, Spain.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 100 million
Coût total (montant approximatif)
Not disclosed.
Aspects environnementaux
The project mainly concerns investments in research and development (R&D) that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Passation des marchés
The promoter is a private company not operating in the Utilities sector and not having the status of a contracting authority. Thus it is not covered by EU directives on procurement. However, the promoter’s procurement procedures are expected to be in line with EIB guidelines for private-sector projects. The Bank’s services will verify details during the project due diligence.
Statut
Signé - 28/10/2015
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).